The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma

Abstract To evaluate the clinical value of polyethylene glycolized recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) for hematopoietic reconstitution after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) patients. This study analyzed data from 70 N...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ruiqi Wang, Hao Tian, Zhenxing Zhu, Dan Cong, Yuansong Bai, Wenlong Zhang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2025-08-01
Colección:	Scientific Reports
Materias:	Recombinant human granulocyte stimulating factor Newly diagnosed multiple myeloma Autologous stem cell transplantation Hematopoietic reconstitution
Acceso en línea:	https://doi.org/10.1038/s41598-025-15360-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!